Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07309354Completed
Open-label, single-arm trial of tizanidine in Musculoskeletal pain, sponsored by Uşak University. Primary endpoint: Change in Acoustic Reflex Threshold at 7 days. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07309354.